<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">Like IL-6, IL-1 plays a key role in hyper-inflammation, and so it has been hypothesised that the use of IL-1 blockers is a further possible therapeutic strategy for COVID-19 [
 <xref rid="bb0040" ref-type="bibr">8</xref>].
</p>
